SECTION 1
Patients—not companies, not regulators, not healthcare providers, payers, or investors—are the ultimate consumers of medicines and treatments. In this section, a Parexel expert and rare disease patient herself, along with a valued sponsor, share insights from the perspective of patients and caregivers, and navigating the challenging, fast-changing rare disease space.
Stay current with novel thinking and actionable insights from our experts.
At Parexel, rare disease clinical research is an integral part of what we do, and we take it personally. Our Center of Excellence for Rare Disease helps sponsors maximize success in rare disease drug development. The way we integrate clinical and regulatory consulting expertise gives customers the most efficient path to designing, planning, and executing even the most complex trials. Multidisciplinary clinical and commercial teams can help you navigate adaptive study design by guiding you toward optimal endpoints for rare disease trials. Accelerate your drug development and maximize the chances of market access success with Parexel.